But
a new study of more than 100 children who were exposed to cancer
treatment during the last two trimesters of their mother’s pregnancy
showed they had normal cognitive and cardiac function, researchers
reported on Monday.
“The
main message of this study is that termination of pregnancy is not
necessarily warranted, and that early preterm delivery to be able to do
cancer treatment isn’t warranted, either,” said Dr. Elyce H. Cardonick, a
maternal-fetal specialist at Cooper Medical School of Rowan University
in Camden, N.J., who was not involved in the new research.
The study, published in The New England Journal of Medicine, was to be presented Monday at the European Cancer Congress in Vienna.
“We
didn’t find any difference in cardiac functioning or cognitive function
between children exposed to cancer treatment in utero and the control
group,” said Dr. Frédéric Amant, the lead author of the study and a
professor of obstetrics and gynecology at the Katholieke Universiteit
Leuven in Belgium.
“To some extent, it’s surprising because cancer treatment is quite toxic,” he said, “and we know most chemotherapy drugs cross the placenta.”
None of the women underwent chemotherapy in the first trimester, because the risk of causing serious birth defects is greatest during that period.
No comments:
Post a Comment